TAF4B Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83615
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for TAF4B Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human TAF4B. Peptide sequence: TPGKPLNTVTTLKPSSLGASSTPSNEPNLKAENSAAVQINLSPTMLENVK The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for TAF4B Antibody
Western Blot: TAF4B Antibody [NBP2-83615]
Western Blot: TAF4B Antibody [NBP2-83615] - Host: Rabbit. Target Name: TAF4B. Sample Type: COLO205 Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for TAF4B Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TAF4B
Alternate Names
TAF(II)105, TAF2C2, TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa, TAFII105, TAFII-105, TATA box binding protein (TBP)-associated factor 4B, TATA box binding protein (TBP)-associated factor, RNA polymerase II, C2, 105kD, transcription initiation factor TFIID 105 kD subunit, transcription initiation factor TFIID 105 kDa subunit, transcription initiation factor TFIID subunit 4B
Gene Symbol
TAF4B
Additional TAF4B Products
Product Specific Notices for TAF4B Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...